NCT00004165View on ClinicalTrials.gov

Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1999

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
BIOLOGICAL

filgrastim

DRUG

melphalan

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

60611

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00004165 - Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter